XTANT MEDICAL HOLDINGS, INC. (XTNT) Spending and interest coverage
- R&D / revenue · 12 months: Value 2.03%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 2.73%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value -3.80×; Formula and calculation Operating income ÷ reported interest expense..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 2.03% | Research and development expense / revenue. Period ending 2026-06-30. $2.22M ÷ $109.53M × 100 ≈ 2.03% |
| Stock-based compensation / revenue · 12 months | 2.73% | Share-based compensation / revenue. Period ending 2026-06-30. $2.99M ÷ $109.53M × 100 ≈ 2.73% |
| Interest coverage · 12 months | -3.80× | Operating income ÷ reported interest expense. $-10.49M ÷ $2.76M ≈ -3.80× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 2.22M USD | Research and Development Expense |
| Revenue | 109.53M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 2.99M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -10.49M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | 2.76M USD | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: Reported. Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.22M | $109.53M | $2.99M | $-10.49M | $2.76M | 2.03% | 2.73% | -3.80× | Reported |
| 2026-03-31 | $2.09M | $121.91M | $2.88M | $3.30M | $3.23M | 1.72% | 2.36% | 1.02× | Reported |
| 2025-12-31 | $2.10M | $133.93M | $2.89M | $7.28M | $3.67M | 1.57% | 2.16% | 1.98× | Reported |
| 2025-09-30 | $2.17M | $133.08M | $3.00M | $6.35M | (m) | 1.63% | 2.26% | (m) | (m) |
| 2025-06-30 | $2.23M | $127.77M | $3.50M | $29.00K | $4.38M | 1.75% | 2.74% | 0.01× | Reported |
| 2025-03-31 | $2.30M | $122.30M | $3.96M | $-7.54M | $4.37M | 1.88% | 3.24% | -1.73× | Reported |
| 2024-12-31 | $2.38M | $117.27M | $4.12M | $-12.07M | $4.16M | 2.03% | 3.51% | -2.90× | Reported |
| 2024-09-30 | $2.35M | $113.86M | $4.21M | $-14.00M | (m) | 2.07% | 3.70% | (m) | (m) |
| 2024-06-30 | $2.15M | $110.94M | $3.82M | $-13.61M | (m) | 1.93% | 3.44% | (m) | (m) |
| 2024-03-31 | $1.69M | $101.23M | $3.03M | $-12.05M | $3.20M | 1.67% | 3.00% | -3.77× | Reported |
| 2023-12-31 | $1.34M | $91.30M | $2.74M | $-10.16M | $2.94M | 1.46% | 3.00% | -3.46× | Reported |
| 2023-09-30 | $1.08M | $78.47M | $2.44M | $-8.08M | $2.62M | 1.37% | 3.11% | -3.09× | Reported |
| 2023-06-30 | $815.00K | $67.91M | $2.34M | $-6.59M | $2.29M | 1.20% | 3.44% | -2.87× | Reported |
| 2023-03-31 | $876.00K | $62.95M | $2.47M | $-6.50M | $1.91M | 1.39% | 3.92% | -3.41× | Reported |
| 2022-12-31 | $915.00K | $57.97M | $2.46M | $-6.75M | $1.69M | 1.58% | 4.25% | -3.99× | Reported |
| 2022-09-30 | $834.00K | $56.67M | $2.53M | $-6.94M | $1.66M | 1.47% | 4.47% | -4.17× | Reported |
| 2022-06-30 | $866.00K | $55.98M | $2.47M | $-6.49M | $1.55M | 1.55% | 4.42% | -4.18× | Reported |
| 2022-03-31 | $869.00K | $55.68M | $2.37M | $-5.68M | $1.35M | 1.56% | 4.25% | -4.20× | Reported |
| 2021-12-31 | $870.00K | $55.26M | $2.21M | $-3.85M | $995.00K | 1.57% | 4.00% | -3.87× | Reported |
| 2021-09-30 | $847.00K | $55.31M | $1.86M | $-1.70M | $1.25M | 1.53% | 3.36% | -1.37× | Reported |
| 2021-06-30 | $762.00K | $55.55M | $1.52M | $501.00K | $3.01M | 1.37% | 2.73% | 0.17× | Reported |
| 2021-03-31 | $626.00K | $51.10M | $1.27M | $607.00K | $4.87M | 1.23% | 2.49% | 0.12× | Reported |
| 2020-12-31 | $657.00K | $53.34M | $1.08M | $-751.00K | $5.98M | 1.23% | 2.03% | -0.13× | Reported |
| 2020-09-30 | $786.00K | $56.29M | $985.00K | $-1.31M | $6.53M | 1.40% | 1.75% | -0.20× | Reported |
| 2020-06-30 | $813.00K | $57.99M | $843.00K | $-2.77M | $5.62M | 1.40% | 1.45% | -0.49× | Reported |
| 2020-03-31 | $915.00K | $62.73M | $662.00K | $-2.95M | $4.86M | 1.46% | 1.06% | -0.61× | Reported |
| 2019-12-31 | $932.00K | $64.68M | $515.00K | $-2.25M | $5.77M | 1.44% | 0.80% | -0.39× | Reported |
| 2019-09-30 | $1.20M | $65.98M | $455.00K | $-56.66M | $6.49M | 1.82% | 0.69% | -8.73× | Reported |
| 2019-06-30 | $1.34M | $67.53M | $502.00K | $-57.39M | $7.10M | 1.99% | 0.74% | -8.09× | Reported |
| 2019-03-31 | $1.55M | $71.00M | $452.00K | $-59.09M | $8.62M | 2.18% | 0.64% | -6.86× | Reported |
| 2018-12-31 | $1.70M | $72.20M | $694.00K | $-60.08M | $10.14M | 2.36% | 0.96% | -5.92× | Reported |
| 2018-09-30 | $1.78M | (m) | $203.81K | $-29.60M | $12.32M | (m) | (m) | -2.40× | Reported |
| 2018-06-30 | $1.93M | (m) | $219.81K | $-32.83M | $14.34M | (m) | (m) | -2.29× | Reported |
| 2018-03-31 | $2.16M | $78.46M | $345.81K | $-36.92M | $14.85M | 2.75% | 0.44% | -2.49× | Reported |
| 2017-12-31 | $2.44M | $82.61M | $211.81K | $-37.83M | $14.70M | 2.95% | 0.26% | -2.57× | Reported |
| 2017-09-30 | $2.64M | $87.75M | $592.89K | $-11.93M | $13.83M | 3.01% | 0.68% | -0.86× | Reported |
| 2017-06-30 | $3.07M | $91.05M | $648.79K | $-9.73M | $13.18M | 3.37% | 0.71% | -0.74× | Reported |
| 2017-03-31 | $3.21M | $91.11M | $617.33K | $-7.13M | $12.84M | 3.52% | 0.68% | -0.56× | Reported |
| 2016-12-31 | $3.41M | $90.00M | $522.99K | $-7.55M | $12.26M | 3.79% | 0.58% | -0.62× | Reported |
| 2016-09-30 | $3.64M | $87.79M | $478.05K | $-10.47M | $11.78M | 4.15% | 0.54% | -0.89× | Reported |
| 2016-06-30 | $3.51M | $82.39M | $663.72K | $-13.45M | $10.73M | 4.25% | 0.81% | -1.25× | Reported |
| 2016-03-31 | $3.01M | $70.82M | $742.84K | $-12.71M | $9.13M | 4.25% | 1.05% | -1.39× | Reported |
| 2015-12-31 | $2.55M | $59.35M | $836.74K | $-12.08M | $7.73M | 4.29% | 1.41% | -1.56× | Reported |
| 2015-09-30 | $2.01M | $46.17M | $878.21K | $-10.49M | $6.38M | 4.35% | 1.90% | -1.65× | Reported |
| 2015-06-30 | $1.59M | $36.93M | $710.84K | $-6.86M | $5.76M | 4.31% | 1.92% | -1.19× | Reported |
| 2015-03-31 | $1.62M | $35.92M | $843.08K | $-6.81M | $5.82M | 4.52% | 2.35% | -1.17× | Reported |
| 2014-12-31 | $1.44M | $35.33M | $935.32K | $-6.26M | $5.66M | 4.08% | 2.65% | -1.11× | Reported |
| 2014-09-30 | (m) | $34.51M | $1.17M | $-7.33M | $5.43M | (m) | 3.40% | -1.35× | Reported |
| 2014-06-30 | (m) | $33.98M | $1.27M | $-8.43M | $5.13M | (m) | 3.74% | -1.64× | Reported |
| 2014-03-31 | (m) | $33.37M | $1.13M | $-8.97M | $4.86M | (m) | 3.39% | -1.84× | Reported |
| 2013-12-31 | (m) | $33.07M | $838.85K | $-9.01M | $4.65M | (m) | 2.54% | -1.94× | Reported |
| 2013-09-30 | (m) | $32.94M | $1.04M | $-8.98M | $4.02M | (m) | 3.17% | -2.23× | Reported |
| 2013-06-30 | (m) | $33.89M | $752.76K | $-6.42M | $3.69M | (m) | 2.22% | -1.74× | Reported |
| 2013-03-31 | (m) | $33.83M | $1.07M | $-4.90M | $2.76M | (m) | 3.15% | -1.78× | Reported |
| 2012-12-31 | (m) | $32.98M | $1.55M | $-4.94M | $1.86M | (m) | 4.71% | -2.65× | Reported |
| 2012-09-30 | (m) | (m) | $1.97M | $-4.08M | $1.40M | (m) | (m) | -2.91× | Reported |
| 2012-06-30 | (m) | (m) | $2.92M | $-5.85M | $1.07M | (m) | (m) | -5.46× | Reported |
| 2012-03-31 | (m) | (m) | $2.41M | $-5.79M | $933.02K | (m) | (m) | -6.20× | Reported |
| 2011-12-31 | (m) | (m) | $2.56M | $-6.45M | $1.16M | (m) | (m) | -5.55× | Reported |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | $2.85M | $-8.61M | $1.65M | (m) | (m) | -5.23× | Reported |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |